A Randomized Phase II Clinical Trial of an Adenovirus-Mediated Endostatin Gene (E10A) Combined With Cisplatin and Paclitaxel in Patients With Head and Neck Cancer.
Phase of Trial: Phase II
Latest Information Update: 27 Feb 2017
At a glance
- Drugs Endostatin gene therapy (Primary) ; Cisplatin; Paclitaxel
- Indications Head and neck cancer; Nasopharyngeal cancer
- Focus Therapeutic Use
- 04 Jun 2010 Preliminary results from 68 patients presented at 46th Annual Meeting of the American Society of Clinical Oncology (ASCO).
- 05 Mar 2008 New trial record.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History